First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2011-06-03 17:31:59Open Document File Size: 135,28 KBShare Result on FacebookCityWEST CHESTER / /CompanyJohnson & Johnson / Dexcom Inc. / New England Journal / Animas Corporation / Animas Corporation As / /ContinentEurope / /CountryGermany / France / Italy / United Kingdom / Sweden / / /EventFDA Phase / /IndustryTermcontinuous glucose sensing technologies / life‐performance technology / healthcare industry / diabetes tools / ‐contrast colour pump screen technology / integrated product / sensor technology / pump systems / hour‐by‐hour management / ‐performance insulin pump technology / communications software / /MedicalConditionlong‐term diabetes complications / chronic condition / disease / diabetes / /MedicalTreatmentinsulin pump / /OrganizationInternational Diabetes Federation / /PersonHenry Anhalt / Mark Approval / Caroline Pavis / / /PositionChief Medical Officer / leader / forward / Private / /ProductEurope WEST CHESTER / Europe / Animas / /ProvinceOrStatePennsylvania / /PublishedMediumNew England Journal of Medicine / /RegionNew England / /Technologyhigh‐performance insulin pump technology / sensor technology / G4™ CGM technology / continuous glucose sensing technologies / state‐of‐the‐art CGM technology / CGM technology / high‐contrast colour pump screen technology / life‐performance technology / /URLwww.sec.gov / http /SocialTag |